The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125772931 12577293 1 I 20160706 20160720 20160720 EXP CA-VALIDUS PHARMACEUTICALS LLC-CA-2016VAL002274 VALIDUS 0.00 Y 0.00000 20160720 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125772931 12577293 1 PS METOPROLOL TARTRATE. METOPROLOL TARTRATE 1 UNK 17963
125772931 12577293 2 SS SANDOSTATIN OCTREOTIDE ACETATE 1 Intramuscular 30 MG, QMO (EVERY 4 WEEKS) 0 30 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125772931 12577293 1 Product used for unknown indication
125772931 12577293 2 Neuroendocrine carcinoma

Outcome of event

Event ID CASEID OUTC COD
125772931 12577293 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125772931 12577293 Death
125772931 12577293 Hypertension
125772931 12577293 Therapeutic response decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125772931 12577293 2 20120531 0